A detailed history of State Street Corp transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,002,954 shares of CARA stock, worth $351,033. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,002,954
Previous 1,020,878 1.76%
Holding current value
$351,033
Previous $755,000 20.79%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.52 - $1.05 $9,320 - $18,820
-17,924 Reduced 1.76%
1,002,954 $912,000
Q4 2023

Feb 14, 2024

BUY
$0.6 - $1.65 $57,364 - $157,753
95,608 Added 10.33%
1,020,878 $755,000
Q3 2023

Nov 14, 2023

BUY
$1.67 - $3.33 $9,706 - $19,353
5,812 Added 0.63%
925,270 $1.55 Million
Q2 2023

Aug 14, 2023

SELL
$2.83 - $4.94 $2.78 Million - $4.86 Million
-983,484 Reduced 51.68%
919,458 $2.6 Million
Q1 2023

May 15, 2023

BUY
$4.89 - $12.27 $617,210 - $1.55 Million
126,219 Added 7.1%
1,902,942 $9.34 Million
Q4 2022

Feb 14, 2023

SELL
$8.88 - $12.77 $903,184 - $1.3 Million
-101,710 Reduced 5.41%
1,776,723 $19.1 Million
Q3 2022

Nov 15, 2022

SELL
$8.24 - $12.56 $627,171 - $955,979
-76,113 Reduced 3.89%
1,878,433 $17.6 Million
Q2 2022

Aug 15, 2022

BUY
$7.45 - $13.84 $2.04 Million - $3.79 Million
273,947 Added 16.3%
1,954,546 $17.8 Million
Q1 2022

May 16, 2022

BUY
$9.94 - $12.65 $1.83 Million - $2.33 Million
184,099 Added 12.3%
1,680,599 $20.4 Million
Q4 2021

Feb 14, 2022

SELL
$11.99 - $18.14 $91,915 - $139,061
-7,666 Reduced 0.51%
1,496,500 $18.2 Million
Q3 2021

Nov 15, 2021

SELL
$11.55 - $16.06 $1.31 Million - $1.82 Million
-113,612 Reduced 7.02%
1,504,166 $23.2 Million
Q2 2021

Aug 16, 2021

BUY
$12.38 - $29.19 $8.63 Million - $20.3 Million
696,893 Added 75.68%
1,617,778 $23.1 Million
Q1 2021

May 17, 2021

SELL
$15.07 - $21.71 $627,876 - $904,525
-41,664 Reduced 4.33%
920,885 $20 Million
Q4 2020

Feb 16, 2021

BUY
$12.72 - $16.16 $165,563 - $210,338
13,016 Added 1.37%
962,549 $14.6 Million
Q3 2020

Nov 10, 2020

SELL
$12.34 - $17.92 $652,539 - $947,609
-52,880 Reduced 5.28%
949,533 $12.1 Million
Q2 2020

Aug 14, 2020

SELL
$12.39 - $17.33 $231,160 - $323,325
-18,657 Reduced 1.83%
1,002,413 $17.1 Million
Q1 2020

May 11, 2020

BUY
$9.12 - $17.78 $9.31 Million - $18.2 Million
1,021,070 New
1,021,070 $13.5 Million

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $18.8M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.